(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-03 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 1102140
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Tue Sep 2024 | 3.99 | 3.89 | 4.05 | 3.84 | 1.989 times |
| 30 Fri Aug 2024 | 3.87 | 3.84 | 3.90 | 3.79 | 2.256 times |
| 30 Fri Aug 2024 | 3.87 | 3.84 | 3.90 | 3.79 | 2.256 times |
| 29 Thu Aug 2024 | 3.83 | 3.85 | 3.89 | 3.82 | 0.413 times |
| 28 Wed Aug 2024 | 3.85 | 3.87 | 3.92 | 3.83 | 0.512 times |
| 27 Tue Aug 2024 | 3.87 | 3.87 | 3.90 | 3.81 | 0.424 times |
| 26 Mon Aug 2024 | 3.87 | 3.94 | 3.94 | 3.87 | 0.698 times |
| 23 Fri Aug 2024 | 3.89 | 3.85 | 3.93 | 3.84 | 0.871 times |
| 22 Thu Aug 2024 | 3.81 | 3.92 | 3.92 | 3.78 | 0.603 times |
| 21 Wed Aug 2024 | 3.87 | 3.85 | 3.94 | 3.80 | 0.967 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 4, for a target of 3.9 or 3.78
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 2.63 |
| Downside Target | 2.92 |
| Downside Target | 3.05 |
| Downside Target | 3.30 |
| Downside Target | 3.44 |
| Downside Target | 3.58 |
| Downside Target | 3.79 |
| Downside Target | 3.94 |
| Downside Target | 3.95 |
| Downside Target | 3.98 |
| Upside Target | 4.05 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 3.87 |
| Downside Intraday Target | 3.75 |
| Upside Intraday Target | 4.08 |
| Upside Intraday Target | 4.17 |
| Downside Intraday Target | 3.96 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Tue Sep 2024 | 3.99 | 3.89 | 4.05 | 3.84 | 0.882 times |
| 30 Fri Aug 2024 | 3.87 | 3.84 | 3.90 | 3.79 | 0.524 times |
| 30 Fri Aug 2024 | 3.87 | 3.94 | 3.94 | 3.79 | 1.108 times |
| 23 Fri Aug 2024 | 3.89 | 3.72 | 3.94 | 3.68 | 1.285 times |
| 16 Fri Aug 2024 | 3.71 | 3.66 | 3.95 | 3.58 | 0.741 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Tue Sep 2024 | 3.99 | 3.89 | 4.05 | 3.84 | 0.103 times |
| 30 Fri Aug 2024 | 3.87 | 3.64 | 3.95 | 3.30 | 1.02 times |
| 31 Wed Jul 2024 | 3.77 | 3.07 | 3.98 | 3.05 | 0.882 times |
| 28 Fri Jun 2024 | 3.09 | 3.36 | 3.64 | 2.92 | 1.294 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.89 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.89 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.